Kevin Charles Gorman
Director at Neurocrine Biosciences; Director at Xencor. Based in San Diego, California.
- Rank
- 1758th of 14,452
- Companies held
- 2
- Largest holding
- NBIX, 99.1% of total
- Latest SEC filing
- Sep 11, 2026
What the $81.8M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Neurocrine Biosciences NBIX Common Stock | Directly | 517,797 | $156.59 | $81.1M | 99.1% | Form 4, Sep 11, 2026 |
| Xencor XNCR Common Stock | Directly | 21,680 | $34.01 | $737K | 0.9% | Form 4, Jun 16, 2026 |
Share counts are the amounts Kevin Charles Gorman reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1755 | Samuel M. Mencoff Director, Packaging Corporation of America. Chicago, IL | $81.9M |
| 1756 | Michael J. Hennigan Executive Chairman, Marathon Petroleum. Houston, TX | $81.9M |
| 1757 | Glade M. Knight Executive Chairman, Apple Hospitality REIT. Richmond, VA | $81.9M |
| 1758 | Kevin Charles Gorman Director, Neurocrine Biosciences. San Diego, CA | $81.8M |
| 1759 | J. Scott Kirby Chief Executive Officer, United Airlines Holdings. Chicago, IL | $81.8M |
| 1760 | Clint Kendric Fergeson Director, Equity Bancshares. Altus, OK | $81.6M |
| 1761 | Robert E. Coletti Director, Cintas. Cincinnati, OH | $81.6M |
Other Neurocrine Biosciences insiders
All NBIX insiders- Kyle Gano$24.3MChief Executive Officer. #4475 overall
- Gary A. Lyons$19.1MDirector. #4752 overall
- Eric Benevich$10.5MChief Commercial Officer. #8450 overall
- Darin Lippoldt$8.9MChief Legal Officer. #9599 overall
- Eiry Roberts$8.0MChief Medical Officer. #9979 overall
- William H. Rastetter$6.8MDirector. #8559 overall
Questions
How much stock does Kevin Charles Gorman own?
Kevin Charles Gorman holds $81,819,169 in listed stock based on SEC filings and current prices, mostly Neurocrine Biosciences (NBIX). That ranks 1758th on the Stock Rich List.
Is this Kevin Charles Gorman's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Kevin Charles Gorman last buy or sell stock?
The most recent open-market trade on file is a sale of 7,527 XNCR shares on Jun 15, 2026 at $12.31.